Global Therapeutic Proteins and Oral Vaccines Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Page: 111

Published Date: 10 Jan 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

Therapeutic proteins are engineered in the laboratory for pharmaceutical use. They include non-covalent binders, enzymes and albumin and therefore have a wide range of treatment applications. Oral vaccines are biologically prepared products, which provide active acquired immunity to diseases. There are currently oral vaccines targeting cholera, polio, rotavirus, smallpox and yellow fever, among others. Oral vaccines comprise an agent resembling the disease-causing microorganism, such as a live attenuated or killed viral particle or the micro-organisms toxins or surface proteins.

According to our (Global Info Research) latest study, the global Therapeutic Proteins and Oral Vaccines market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

This report is a detailed and comprehensive analysis for global Therapeutic Proteins and Oral Vaccines market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:
Global Therapeutic Proteins and Oral Vaccines market size and forecasts, in consumption value ($ Million), 2018-2029
Global Therapeutic Proteins and Oral Vaccines market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Therapeutic Proteins and Oral Vaccines market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Therapeutic Proteins and Oral Vaccines market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Therapeutic Proteins and Oral Vaccines
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Therapeutic Proteins and Oral Vaccines market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott, Amgen, Biogen, Eli Lilly and Company and Roche, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market segmentation
Therapeutic Proteins and Oral Vaccines market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    Therapeutic Proteins
    Oral Vaccines

Market segment by Application
    Hospital Pharmacies
    Retail Pharmacies
    Online Pharmacies

Market segment by players, this report covers
    Abbott
    Amgen
    Biogen
    Eli Lilly and Company
    Roche
    Johnson and Johnson
    Merck
    Novo Nordisk
    Pfizer
    Sanofi
    Serum Institute of India
    Emergent Biosolutions
    TransAlgae
    MigVax
    Lumen Bioscience

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Therapeutic Proteins and Oral Vaccines product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Therapeutic Proteins and Oral Vaccines, with revenue, gross margin and global market share of Therapeutic Proteins and Oral Vaccines from 2018 to 2023.
Chapter 3, the Therapeutic Proteins and Oral Vaccines competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Therapeutic Proteins and Oral Vaccines market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Therapeutic Proteins and Oral Vaccines.
Chapter 13, to describe Therapeutic Proteins and Oral Vaccines research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Therapeutic Proteins and Oral Vaccines
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Therapeutic Proteins and Oral Vaccines by Type
        1.3.1 Overview: Global Therapeutic Proteins and Oral Vaccines Market Size by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Global Therapeutic Proteins and Oral Vaccines Consumption Value Market Share by Type in 2022
        1.3.3 Therapeutic Proteins
        1.3.4 Oral Vaccines
    1.4 Global Therapeutic Proteins and Oral Vaccines Market by Application
        1.4.1 Overview: Global Therapeutic Proteins and Oral Vaccines Market Size by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Hospital Pharmacies
        1.4.3 Retail Pharmacies
        1.4.4 Online Pharmacies
    1.5 Global Therapeutic Proteins and Oral Vaccines Market Size & Forecast
    1.6 Global Therapeutic Proteins and Oral Vaccines Market Size and Forecast by Region
        1.6.1 Global Therapeutic Proteins and Oral Vaccines Market Size by Region: 2018 VS 2022 VS 2029
        1.6.2 Global Therapeutic Proteins and Oral Vaccines Market Size by Region, (2018-2029)
        1.6.3 North America Therapeutic Proteins and Oral Vaccines Market Size and Prospect (2018-2029)
        1.6.4 Europe Therapeutic Proteins and Oral Vaccines Market Size and Prospect (2018-2029)
        1.6.5 Asia-Pacific Therapeutic Proteins and Oral Vaccines Market Size and Prospect (2018-2029)
        1.6.6 South America Therapeutic Proteins and Oral Vaccines Market Size and Prospect (2018-2029)
        1.6.7 Middle East and Africa Therapeutic Proteins and Oral Vaccines Market Size and Prospect (2018-2029)

2 Company Profiles
    2.1 Abbott
        2.1.1 Abbott Details
        2.1.2 Abbott Major Business
        2.1.3 Abbott Therapeutic Proteins and Oral Vaccines Product and Solutions
        2.1.4 Abbott Therapeutic Proteins and Oral Vaccines Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 Abbott Recent Developments and Future Plans
    2.2 Amgen
        2.2.1 Amgen Details
        2.2.2 Amgen Major Business
        2.2.3 Amgen Therapeutic Proteins and Oral Vaccines Product and Solutions
        2.2.4 Amgen Therapeutic Proteins and Oral Vaccines Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 Amgen Recent Developments and Future Plans
    2.3 Biogen
        2.3.1 Biogen Details
        2.3.2 Biogen Major Business
        2.3.3 Biogen Therapeutic Proteins and Oral Vaccines Product and Solutions
        2.3.4 Biogen Therapeutic Proteins and Oral Vaccines Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 Biogen Recent Developments and Future Plans
    2.4 Eli Lilly and Company
        2.4.1 Eli Lilly and Company Details
        2.4.2 Eli Lilly and Company Major Business
        2.4.3 Eli Lilly and Company Therapeutic Proteins and Oral Vaccines Product and Solutions
        2.4.4 Eli Lilly and Company Therapeutic Proteins and Oral Vaccines Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 Eli Lilly and Company Recent Developments and Future Plans
    2.5 Roche
        2.5.1 Roche Details
        2.5.2 Roche Major Business
        2.5.3 Roche Therapeutic Proteins and Oral Vaccines Product and Solutions
        2.5.4 Roche Therapeutic Proteins and Oral Vaccines Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 Roche Recent Developments and Future Plans
    2.6 Johnson and Johnson
        2.6.1 Johnson and Johnson Details
        2.6.2 Johnson and Johnson Major Business
        2.6.3 Johnson and Johnson Therapeutic Proteins and Oral Vaccines Product and Solutions
        2.6.4 Johnson and Johnson Therapeutic Proteins and Oral Vaccines Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 Johnson and Johnson Recent Developments and Future Plans
    2.7 Merck
        2.7.1 Merck Details
        2.7.2 Merck Major Business
        2.7.3 Merck Therapeutic Proteins and Oral Vaccines Product and Solutions
        2.7.4 Merck Therapeutic Proteins and Oral Vaccines Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 Merck Recent Developments and Future Plans
    2.8 Novo Nordisk
        2.8.1 Novo Nordisk Details
        2.8.2 Novo Nordisk Major Business
        2.8.3 Novo Nordisk Therapeutic Proteins and Oral Vaccines Product and Solutions
        2.8.4 Novo Nordisk Therapeutic Proteins and Oral Vaccines Revenue, Gross Margin and Market Share (2018-2023)
        2.8.5 Novo Nordisk Recent Developments and Future Plans
    2.9 Pfizer
        2.9.1 Pfizer Details
        2.9.2 Pfizer Major Business
        2.9.3 Pfizer Therapeutic Proteins and Oral Vaccines Product and Solutions
        2.9.4 Pfizer Therapeutic Proteins and Oral Vaccines Revenue, Gross Margin and Market Share (2018-2023)
        2.9.5 Pfizer Recent Developments and Future Plans
    2.10 Sanofi
        2.10.1 Sanofi Details
        2.10.2 Sanofi Major Business
        2.10.3 Sanofi Therapeutic Proteins and Oral Vaccines Product and Solutions
        2.10.4 Sanofi Therapeutic Proteins and Oral Vaccines Revenue, Gross Margin and Market Share (2018-2023)
        2.10.5 Sanofi Recent Developments and Future Plans
    2.11 Serum Institute of India
        2.11.1 Serum Institute of India Details
        2.11.2 Serum Institute of India Major Business
        2.11.3 Serum Institute of India Therapeutic Proteins and Oral Vaccines Product and Solutions
        2.11.4 Serum Institute of India Therapeutic Proteins and Oral Vaccines Revenue, Gross Margin and Market Share (2018-2023)
        2.11.5 Serum Institute of India Recent Developments and Future Plans
    2.12 Emergent Biosolutions
        2.12.1 Emergent Biosolutions Details
        2.12.2 Emergent Biosolutions Major Business
        2.12.3 Emergent Biosolutions Therapeutic Proteins and Oral Vaccines Product and Solutions
        2.12.4 Emergent Biosolutions Therapeutic Proteins and Oral Vaccines Revenue, Gross Margin and Market Share (2018-2023)
        2.12.5 Emergent Biosolutions Recent Developments and Future Plans
    2.13 TransAlgae
        2.13.1 TransAlgae Details
        2.13.2 TransAlgae Major Business
        2.13.3 TransAlgae Therapeutic Proteins and Oral Vaccines Product and Solutions
        2.13.4 TransAlgae Therapeutic Proteins and Oral Vaccines Revenue, Gross Margin and Market Share (2018-2023)
        2.13.5 TransAlgae Recent Developments and Future Plans
    2.14 MigVax
        2.14.1 MigVax Details
        2.14.2 MigVax Major Business
        2.14.3 MigVax Therapeutic Proteins and Oral Vaccines Product and Solutions
        2.14.4 MigVax Therapeutic Proteins and Oral Vaccines Revenue, Gross Margin and Market Share (2018-2023)
        2.14.5 MigVax Recent Developments and Future Plans
    2.15 Lumen Bioscience
        2.15.1 Lumen Bioscience Details
        2.15.2 Lumen Bioscience Major Business
        2.15.3 Lumen Bioscience Therapeutic Proteins and Oral Vaccines Product and Solutions
        2.15.4 Lumen Bioscience Therapeutic Proteins and Oral Vaccines Revenue, Gross Margin and Market Share (2018-2023)
        2.15.5 Lumen Bioscience Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Therapeutic Proteins and Oral Vaccines Revenue and Share by Players (2018-2023)
    3.2 Market Share Analysis (2022)
        3.2.1 Market Share of Therapeutic Proteins and Oral Vaccines by Company Revenue
        3.2.2 Top 3 Therapeutic Proteins and Oral Vaccines Players Market Share in 2022
        3.2.3 Top 6 Therapeutic Proteins and Oral Vaccines Players Market Share in 2022
    3.3 Therapeutic Proteins and Oral Vaccines Market: Overall Company Footprint Analysis
        3.3.1 Therapeutic Proteins and Oral Vaccines Market: Region Footprint
        3.3.2 Therapeutic Proteins and Oral Vaccines Market: Company Product Type Footprint
        3.3.3 Therapeutic Proteins and Oral Vaccines Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Therapeutic Proteins and Oral Vaccines Consumption Value and Market Share by Type (2018-2023)
    4.2 Global Therapeutic Proteins and Oral Vaccines Market Forecast by Type (2024-2029)

5 Market Size Segment by Application
    5.1 Global Therapeutic Proteins and Oral Vaccines Consumption Value Market Share by Application (2018-2023)
    5.2 Global Therapeutic Proteins and Oral Vaccines Market Forecast by Application (2024-2029)

6 North America
    6.1 North America Therapeutic Proteins and Oral Vaccines Consumption Value by Type (2018-2029)
    6.2 North America Therapeutic Proteins and Oral Vaccines Consumption Value by Application (2018-2029)
    6.3 North America Therapeutic Proteins and Oral Vaccines Market Size by Country
        6.3.1 North America Therapeutic Proteins and Oral Vaccines Consumption Value by Country (2018-2029)
        6.3.2 United States Therapeutic Proteins and Oral Vaccines Market Size and Forecast (2018-2029)
        6.3.3 Canada Therapeutic Proteins and Oral Vaccines Market Size and Forecast (2018-2029)
        6.3.4 Mexico Therapeutic Proteins and Oral Vaccines Market Size and Forecast (2018-2029)

7 Europe
    7.1 Europe Therapeutic Proteins and Oral Vaccines Consumption Value by Type (2018-2029)
    7.2 Europe Therapeutic Proteins and Oral Vaccines Consumption Value by Application (2018-2029)
    7.3 Europe Therapeutic Proteins and Oral Vaccines Market Size by Country
        7.3.1 Europe Therapeutic Proteins and Oral Vaccines Consumption Value by Country (2018-2029)
        7.3.2 Germany Therapeutic Proteins and Oral Vaccines Market Size and Forecast (2018-2029)
        7.3.3 France Therapeutic Proteins and Oral Vaccines Market Size and Forecast (2018-2029)
        7.3.4 United Kingdom Therapeutic Proteins and Oral Vaccines Market Size and Forecast (2018-2029)
        7.3.5 Russia Therapeutic Proteins and Oral Vaccines Market Size and Forecast (2018-2029)
        7.3.6 Italy Therapeutic Proteins and Oral Vaccines Market Size and Forecast (2018-2029)

8 Asia-Pacific
    8.1 Asia-Pacific Therapeutic Proteins and Oral Vaccines Consumption Value by Type (2018-2029)
    8.2 Asia-Pacific Therapeutic Proteins and Oral Vaccines Consumption Value by Application (2018-2029)
    8.3 Asia-Pacific Therapeutic Proteins and Oral Vaccines Market Size by Region
        8.3.1 Asia-Pacific Therapeutic Proteins and Oral Vaccines Consumption Value by Region (2018-2029)
        8.3.2 China Therapeutic Proteins and Oral Vaccines Market Size and Forecast (2018-2029)
        8.3.3 Japan Therapeutic Proteins and Oral Vaccines Market Size and Forecast (2018-2029)
        8.3.4 South Korea Therapeutic Proteins and Oral Vaccines Market Size and Forecast (2018-2029)
        8.3.5 India Therapeutic Proteins and Oral Vaccines Market Size and Forecast (2018-2029)
        8.3.6 Southeast Asia Therapeutic Proteins and Oral Vaccines Market Size and Forecast (2018-2029)
        8.3.7 Australia Therapeutic Proteins and Oral Vaccines Market Size and Forecast (2018-2029)

9 South America
    9.1 South America Therapeutic Proteins and Oral Vaccines Consumption Value by Type (2018-2029)
    9.2 South America Therapeutic Proteins and Oral Vaccines Consumption Value by Application (2018-2029)
    9.3 South America Therapeutic Proteins and Oral Vaccines Market Size by Country
        9.3.1 South America Therapeutic Proteins and Oral Vaccines Consumption Value by Country (2018-2029)
        9.3.2 Brazil Therapeutic Proteins and Oral Vaccines Market Size and Forecast (2018-2029)
        9.3.3 Argentina Therapeutic Proteins and Oral Vaccines Market Size and Forecast (2018-2029)

10 Middle East & Africa
    10.1 Middle East & Africa Therapeutic Proteins and Oral Vaccines Consumption Value by Type (2018-2029)
    10.2 Middle East & Africa Therapeutic Proteins and Oral Vaccines Consumption Value by Application (2018-2029)
    10.3 Middle East & Africa Therapeutic Proteins and Oral Vaccines Market Size by Country
        10.3.1 Middle East & Africa Therapeutic Proteins and Oral Vaccines Consumption Value by Country (2018-2029)
        10.3.2 Turkey Therapeutic Proteins and Oral Vaccines Market Size and Forecast (2018-2029)
        10.3.3 Saudi Arabia Therapeutic Proteins and Oral Vaccines Market Size and Forecast (2018-2029)
        10.3.4 UAE Therapeutic Proteins and Oral Vaccines Market Size and Forecast (2018-2029)

11 Market Dynamics
    11.1 Therapeutic Proteins and Oral Vaccines Market Drivers
    11.2 Therapeutic Proteins and Oral Vaccines Market Restraints
    11.3 Therapeutic Proteins and Oral Vaccines Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry
    11.5 Influence of COVID-19 and Russia-Ukraine War
        11.5.1 Influence of COVID-19
        11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis
    12.1 Therapeutic Proteins and Oral Vaccines Industry Chain
    12.2 Therapeutic Proteins and Oral Vaccines Upstream Analysis
    12.3 Therapeutic Proteins and Oral Vaccines Midstream Analysis
    12.4 Therapeutic Proteins and Oral Vaccines Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Therapeutic Proteins and Oral Vaccines Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global Therapeutic Proteins and Oral Vaccines Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 3. Global Therapeutic Proteins and Oral Vaccines Consumption Value by Region (2018-2023) & (USD Million)
    Table 4. Global Therapeutic Proteins and Oral Vaccines Consumption Value by Region (2024-2029) & (USD Million)
    Table 5. Abbott Company Information, Head Office, and Major Competitors
    Table 6. Abbott Major Business
    Table 7. Abbott Therapeutic Proteins and Oral Vaccines Product and Solutions
    Table 8. Abbott Therapeutic Proteins and Oral Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 9. Abbott Recent Developments and Future Plans
    Table 10. Amgen Company Information, Head Office, and Major Competitors
    Table 11. Amgen Major Business
    Table 12. Amgen Therapeutic Proteins and Oral Vaccines Product and Solutions
    Table 13. Amgen Therapeutic Proteins and Oral Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 14. Amgen Recent Developments and Future Plans
    Table 15. Biogen Company Information, Head Office, and Major Competitors
    Table 16. Biogen Major Business
    Table 17. Biogen Therapeutic Proteins and Oral Vaccines Product and Solutions
    Table 18. Biogen Therapeutic Proteins and Oral Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 19. Biogen Recent Developments and Future Plans
    Table 20. Eli Lilly and Company Company Information, Head Office, and Major Competitors
    Table 21. Eli Lilly and Company Major Business
    Table 22. Eli Lilly and Company Therapeutic Proteins and Oral Vaccines Product and Solutions
    Table 23. Eli Lilly and Company Therapeutic Proteins and Oral Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 24. Eli Lilly and Company Recent Developments and Future Plans
    Table 25. Roche Company Information, Head Office, and Major Competitors
    Table 26. Roche Major Business
    Table 27. Roche Therapeutic Proteins and Oral Vaccines Product and Solutions
    Table 28. Roche Therapeutic Proteins and Oral Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 29. Roche Recent Developments and Future Plans
    Table 30. Johnson and Johnson Company Information, Head Office, and Major Competitors
    Table 31. Johnson and Johnson Major Business
    Table 32. Johnson and Johnson Therapeutic Proteins and Oral Vaccines Product and Solutions
    Table 33. Johnson and Johnson Therapeutic Proteins and Oral Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 34. Johnson and Johnson Recent Developments and Future Plans
    Table 35. Merck Company Information, Head Office, and Major Competitors
    Table 36. Merck Major Business
    Table 37. Merck Therapeutic Proteins and Oral Vaccines Product and Solutions
    Table 38. Merck Therapeutic Proteins and Oral Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 39. Merck Recent Developments and Future Plans
    Table 40. Novo Nordisk Company Information, Head Office, and Major Competitors
    Table 41. Novo Nordisk Major Business
    Table 42. Novo Nordisk Therapeutic Proteins and Oral Vaccines Product and Solutions
    Table 43. Novo Nordisk Therapeutic Proteins and Oral Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 44. Novo Nordisk Recent Developments and Future Plans
    Table 45. Pfizer Company Information, Head Office, and Major Competitors
    Table 46. Pfizer Major Business
    Table 47. Pfizer Therapeutic Proteins and Oral Vaccines Product and Solutions
    Table 48. Pfizer Therapeutic Proteins and Oral Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 49. Pfizer Recent Developments and Future Plans
    Table 50. Sanofi Company Information, Head Office, and Major Competitors
    Table 51. Sanofi Major Business
    Table 52. Sanofi Therapeutic Proteins and Oral Vaccines Product and Solutions
    Table 53. Sanofi Therapeutic Proteins and Oral Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 54. Sanofi Recent Developments and Future Plans
    Table 55. Serum Institute of India Company Information, Head Office, and Major Competitors
    Table 56. Serum Institute of India Major Business
    Table 57. Serum Institute of India Therapeutic Proteins and Oral Vaccines Product and Solutions
    Table 58. Serum Institute of India Therapeutic Proteins and Oral Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 59. Serum Institute of India Recent Developments and Future Plans
    Table 60. Emergent Biosolutions Company Information, Head Office, and Major Competitors
    Table 61. Emergent Biosolutions Major Business
    Table 62. Emergent Biosolutions Therapeutic Proteins and Oral Vaccines Product and Solutions
    Table 63. Emergent Biosolutions Therapeutic Proteins and Oral Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 64. Emergent Biosolutions Recent Developments and Future Plans
    Table 65. TransAlgae Company Information, Head Office, and Major Competitors
    Table 66. TransAlgae Major Business
    Table 67. TransAlgae Therapeutic Proteins and Oral Vaccines Product and Solutions
    Table 68. TransAlgae Therapeutic Proteins and Oral Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 69. TransAlgae Recent Developments and Future Plans
    Table 70. MigVax Company Information, Head Office, and Major Competitors
    Table 71. MigVax Major Business
    Table 72. MigVax Therapeutic Proteins and Oral Vaccines Product and Solutions
    Table 73. MigVax Therapeutic Proteins and Oral Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 74. MigVax Recent Developments and Future Plans
    Table 75. Lumen Bioscience Company Information, Head Office, and Major Competitors
    Table 76. Lumen Bioscience Major Business
    Table 77. Lumen Bioscience Therapeutic Proteins and Oral Vaccines Product and Solutions
    Table 78. Lumen Bioscience Therapeutic Proteins and Oral Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 79. Lumen Bioscience Recent Developments and Future Plans
    Table 80. Global Therapeutic Proteins and Oral Vaccines Revenue (USD Million) by Players (2018-2023)
    Table 81. Global Therapeutic Proteins and Oral Vaccines Revenue Share by Players (2018-2023)
    Table 82. Breakdown of Therapeutic Proteins and Oral Vaccines by Company Type (Tier 1, Tier 2, and Tier 3)
    Table 83. Market Position of Players in Therapeutic Proteins and Oral Vaccines, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
    Table 84. Head Office of Key Therapeutic Proteins and Oral Vaccines Players
    Table 85. Therapeutic Proteins and Oral Vaccines Market: Company Product Type Footprint
    Table 86. Therapeutic Proteins and Oral Vaccines Market: Company Product Application Footprint
    Table 87. Therapeutic Proteins and Oral Vaccines New Market Entrants and Barriers to Market Entry
    Table 88. Therapeutic Proteins and Oral Vaccines Mergers, Acquisition, Agreements, and Collaborations
    Table 89. Global Therapeutic Proteins and Oral Vaccines Consumption Value (USD Million) by Type (2018-2023)
    Table 90. Global Therapeutic Proteins and Oral Vaccines Consumption Value Share by Type (2018-2023)
    Table 91. Global Therapeutic Proteins and Oral Vaccines Consumption Value Forecast by Type (2024-2029)
    Table 92. Global Therapeutic Proteins and Oral Vaccines Consumption Value by Application (2018-2023)
    Table 93. Global Therapeutic Proteins and Oral Vaccines Consumption Value Forecast by Application (2024-2029)
    Table 94. North America Therapeutic Proteins and Oral Vaccines Consumption Value by Type (2018-2023) & (USD Million)
    Table 95. North America Therapeutic Proteins and Oral Vaccines Consumption Value by Type (2024-2029) & (USD Million)
    Table 96. North America Therapeutic Proteins and Oral Vaccines Consumption Value by Application (2018-2023) & (USD Million)
    Table 97. North America Therapeutic Proteins and Oral Vaccines Consumption Value by Application (2024-2029) & (USD Million)
    Table 98. North America Therapeutic Proteins and Oral Vaccines Consumption Value by Country (2018-2023) & (USD Million)
    Table 99. North America Therapeutic Proteins and Oral Vaccines Consumption Value by Country (2024-2029) & (USD Million)
    Table 100. Europe Therapeutic Proteins and Oral Vaccines Consumption Value by Type (2018-2023) & (USD Million)
    Table 101. Europe Therapeutic Proteins and Oral Vaccines Consumption Value by Type (2024-2029) & (USD Million)
    Table 102. Europe Therapeutic Proteins and Oral Vaccines Consumption Value by Application (2018-2023) & (USD Million)
    Table 103. Europe Therapeutic Proteins and Oral Vaccines Consumption Value by Application (2024-2029) & (USD Million)
    Table 104. Europe Therapeutic Proteins and Oral Vaccines Consumption Value by Country (2018-2023) & (USD Million)
    Table 105. Europe Therapeutic Proteins and Oral Vaccines Consumption Value by Country (2024-2029) & (USD Million)
    Table 106. Asia-Pacific Therapeutic Proteins and Oral Vaccines Consumption Value by Type (2018-2023) & (USD Million)
    Table 107. Asia-Pacific Therapeutic Proteins and Oral Vaccines Consumption Value by Type (2024-2029) & (USD Million)
    Table 108. Asia-Pacific Therapeutic Proteins and Oral Vaccines Consumption Value by Application (2018-2023) & (USD Million)
    Table 109. Asia-Pacific Therapeutic Proteins and Oral Vaccines Consumption Value by Application (2024-2029) & (USD Million)
    Table 110. Asia-Pacific Therapeutic Proteins and Oral Vaccines Consumption Value by Region (2018-2023) & (USD Million)
    Table 111. Asia-Pacific Therapeutic Proteins and Oral Vaccines Consumption Value by Region (2024-2029) & (USD Million)
    Table 112. South America Therapeutic Proteins and Oral Vaccines Consumption Value by Type (2018-2023) & (USD Million)
    Table 113. South America Therapeutic Proteins and Oral Vaccines Consumption Value by Type (2024-2029) & (USD Million)
    Table 114. South America Therapeutic Proteins and Oral Vaccines Consumption Value by Application (2018-2023) & (USD Million)
    Table 115. South America Therapeutic Proteins and Oral Vaccines Consumption Value by Application (2024-2029) & (USD Million)
    Table 116. South America Therapeutic Proteins and Oral Vaccines Consumption Value by Country (2018-2023) & (USD Million)
    Table 117. South America Therapeutic Proteins and Oral Vaccines Consumption Value by Country (2024-2029) & (USD Million)
    Table 118. Middle East & Africa Therapeutic Proteins and Oral Vaccines Consumption Value by Type (2018-2023) & (USD Million)
    Table 119. Middle East & Africa Therapeutic Proteins and Oral Vaccines Consumption Value by Type (2024-2029) & (USD Million)
    Table 120. Middle East & Africa Therapeutic Proteins and Oral Vaccines Consumption Value by Application (2018-2023) & (USD Million)
    Table 121. Middle East & Africa Therapeutic Proteins and Oral Vaccines Consumption Value by Application (2024-2029) & (USD Million)
    Table 122. Middle East & Africa Therapeutic Proteins and Oral Vaccines Consumption Value by Country (2018-2023) & (USD Million)
    Table 123. Middle East & Africa Therapeutic Proteins and Oral Vaccines Consumption Value by Country (2024-2029) & (USD Million)
    Table 124. Therapeutic Proteins and Oral Vaccines Raw Material
    Table 125. Key Suppliers of Therapeutic Proteins and Oral Vaccines Raw Materials
List of Figures
    Figure 1. Therapeutic Proteins and Oral Vaccines Picture
    Figure 2. Global Therapeutic Proteins and Oral Vaccines Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global Therapeutic Proteins and Oral Vaccines Consumption Value Market Share by Type in 2022
    Figure 4. Therapeutic Proteins
    Figure 5. Oral Vaccines
    Figure 6. Global Therapeutic Proteins and Oral Vaccines Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 7. Therapeutic Proteins and Oral Vaccines Consumption Value Market Share by Application in 2022
    Figure 8. Hospital Pharmacies Picture
    Figure 9. Retail Pharmacies Picture
    Figure 10. Online Pharmacies Picture
    Figure 11. Global Therapeutic Proteins and Oral Vaccines Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 12. Global Therapeutic Proteins and Oral Vaccines Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 13. Global Market Therapeutic Proteins and Oral Vaccines Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
    Figure 14. Global Therapeutic Proteins and Oral Vaccines Consumption Value Market Share by Region (2018-2029)
    Figure 15. Global Therapeutic Proteins and Oral Vaccines Consumption Value Market Share by Region in 2022
    Figure 16. North America Therapeutic Proteins and Oral Vaccines Consumption Value (2018-2029) & (USD Million)
    Figure 17. Europe Therapeutic Proteins and Oral Vaccines Consumption Value (2018-2029) & (USD Million)
    Figure 18. Asia-Pacific Therapeutic Proteins and Oral Vaccines Consumption Value (2018-2029) & (USD Million)
    Figure 19. South America Therapeutic Proteins and Oral Vaccines Consumption Value (2018-2029) & (USD Million)
    Figure 20. Middle East and Africa Therapeutic Proteins and Oral Vaccines Consumption Value (2018-2029) & (USD Million)
    Figure 21. Global Therapeutic Proteins and Oral Vaccines Revenue Share by Players in 2022
    Figure 22. Therapeutic Proteins and Oral Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
    Figure 23. Global Top 3 Players Therapeutic Proteins and Oral Vaccines Market Share in 2022
    Figure 24. Global Top 6 Players Therapeutic Proteins and Oral Vaccines Market Share in 2022
    Figure 25. Global Therapeutic Proteins and Oral Vaccines Consumption Value Share by Type (2018-2023)
    Figure 26. Global Therapeutic Proteins and Oral Vaccines Market Share Forecast by Type (2024-2029)
    Figure 27. Global Therapeutic Proteins and Oral Vaccines Consumption Value Share by Application (2018-2023)
    Figure 28. Global Therapeutic Proteins and Oral Vaccines Market Share Forecast by Application (2024-2029)
    Figure 29. North America Therapeutic Proteins and Oral Vaccines Consumption Value Market Share by Type (2018-2029)
    Figure 30. North America Therapeutic Proteins and Oral Vaccines Consumption Value Market Share by Application (2018-2029)
    Figure 31. North America Therapeutic Proteins and Oral Vaccines Consumption Value Market Share by Country (2018-2029)
    Figure 32. United States Therapeutic Proteins and Oral Vaccines Consumption Value (2018-2029) & (USD Million)
    Figure 33. Canada Therapeutic Proteins and Oral Vaccines Consumption Value (2018-2029) & (USD Million)
    Figure 34. Mexico Therapeutic Proteins and Oral Vaccines Consumption Value (2018-2029) & (USD Million)
    Figure 35. Europe Therapeutic Proteins and Oral Vaccines Consumption Value Market Share by Type (2018-2029)
    Figure 36. Europe Therapeutic Proteins and Oral Vaccines Consumption Value Market Share by Application (2018-2029)
    Figure 37. Europe Therapeutic Proteins and Oral Vaccines Consumption Value Market Share by Country (2018-2029)
    Figure 38. Germany Therapeutic Proteins and Oral Vaccines Consumption Value (2018-2029) & (USD Million)
    Figure 39. France Therapeutic Proteins and Oral Vaccines Consumption Value (2018-2029) & (USD Million)
    Figure 40. United Kingdom Therapeutic Proteins and Oral Vaccines Consumption Value (2018-2029) & (USD Million)
    Figure 41. Russia Therapeutic Proteins and Oral Vaccines Consumption Value (2018-2029) & (USD Million)
    Figure 42. Italy Therapeutic Proteins and Oral Vaccines Consumption Value (2018-2029) & (USD Million)
    Figure 43. Asia-Pacific Therapeutic Proteins and Oral Vaccines Consumption Value Market Share by Type (2018-2029)
    Figure 44. Asia-Pacific Therapeutic Proteins and Oral Vaccines Consumption Value Market Share by Application (2018-2029)
    Figure 45. Asia-Pacific Therapeutic Proteins and Oral Vaccines Consumption Value Market Share by Region (2018-2029)
    Figure 46. China Therapeutic Proteins and Oral Vaccines Consumption Value (2018-2029) & (USD Million)
    Figure 47. Japan Therapeutic Proteins and Oral Vaccines Consumption Value (2018-2029) & (USD Million)
    Figure 48. South Korea Therapeutic Proteins and Oral Vaccines Consumption Value (2018-2029) & (USD Million)
    Figure 49. India Therapeutic Proteins and Oral Vaccines Consumption Value (2018-2029) & (USD Million)
    Figure 50. Southeast Asia Therapeutic Proteins and Oral Vaccines Consumption Value (2018-2029) & (USD Million)
    Figure 51. Australia Therapeutic Proteins and Oral Vaccines Consumption Value (2018-2029) & (USD Million)
    Figure 52. South America Therapeutic Proteins and Oral Vaccines Consumption Value Market Share by Type (2018-2029)
    Figure 53. South America Therapeutic Proteins and Oral Vaccines Consumption Value Market Share by Application (2018-2029)
    Figure 54. South America Therapeutic Proteins and Oral Vaccines Consumption Value Market Share by Country (2018-2029)
    Figure 55. Brazil Therapeutic Proteins and Oral Vaccines Consumption Value (2018-2029) & (USD Million)
    Figure 56. Argentina Therapeutic Proteins and Oral Vaccines Consumption Value (2018-2029) & (USD Million)
    Figure 57. Middle East and Africa Therapeutic Proteins and Oral Vaccines Consumption Value Market Share by Type (2018-2029)
    Figure 58. Middle East and Africa Therapeutic Proteins and Oral Vaccines Consumption Value Market Share by Application (2018-2029)
    Figure 59. Middle East and Africa Therapeutic Proteins and Oral Vaccines Consumption Value Market Share by Country (2018-2029)
    Figure 60. Turkey Therapeutic Proteins and Oral Vaccines Consumption Value (2018-2029) & (USD Million)
    Figure 61. Saudi Arabia Therapeutic Proteins and Oral Vaccines Consumption Value (2018-2029) & (USD Million)
    Figure 62. UAE Therapeutic Proteins and Oral Vaccines Consumption Value (2018-2029) & (USD Million)
    Figure 63. Therapeutic Proteins and Oral Vaccines Market Drivers
    Figure 64. Therapeutic Proteins and Oral Vaccines Market Restraints
    Figure 65. Therapeutic Proteins and Oral Vaccines Market Trends
    Figure 66. Porters Five Forces Analysis
    Figure 67. Manufacturing Cost Structure Analysis of Therapeutic Proteins and Oral Vaccines in 2022
    Figure 68. Manufacturing Process Analysis of Therapeutic Proteins and Oral Vaccines
    Figure 69. Therapeutic Proteins and Oral Vaccines Industrial Chain
    Figure 70. Methodology
    Figure 71. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Abbott
Amgen
Biogen
Eli Lilly and Company
Roche
Johnson and Johnson
Merck
Novo Nordisk
Pfizer
Sanofi
Serum Institute of India
Emergent Biosolutions
TransAlgae
MigVax
Lumen Bioscience

Related Reports

Global Therapeutic Proteins and Oral Vaccines Supply, Demand and Key Producers, 2023-2029

Global Therapeutic Proteins and Oral Vaccines Supply, Demand and Key Producers, 2023-2029

date 23 Jan 2023

date Pharma & Healthcare

The global Therapeutic Proteins and Oral Vaccines market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Global Therapeutic Proteins and Oral Vaccines Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Therapeutic Proteins and Oral Vaccines Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 04 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Therapeutic Proteins and Oral Vaccines market size was valued at USD 438.3 million in 2023 and is forecast to a readjusted size of USD 643.8 million by 2030 with a CAGR of 5.6% during review period.

Global Therapeutic Proteins and Oral Vaccines Supply, Demand and Key Producers, 2024-2030

Global Therapeutic Proteins and Oral Vaccines Supply, Demand and Key Producers, 2024-2030

date 29 Feb 2024

date Pharma & Healthcare

The global Therapeutic Proteins and Oral Vaccines market size is expected to reach $ 643.8 million by 2030, rising at a market growth of 5.6% CAGR during the forecast period (2024-2030).

Product Tags

Therapeutic Proteins and Oral Vaccines

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>